A natural sweetener, Momordica grosvenori, attenuates the imbalance of cellular immune functions in alloxan-induced diabetic mice

Phytotherapy Research

Volumn 20, Issue 7, 2006, Pages 552-560

  Song, Fangfang ^a   Chen, Weijun ^b   Jia, Wenbo ^a   Yao, Ping ^a   Nussler, Andreas K ^c   Sun, Xiufa ^a   Liu, Liegang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Alloxan; Cellular immune function; Diabetic mice; Momordica grosvenori

Indexed keywords

ALLOXAN; BIOCHEMICAL MARKER; CYTOKINE; GAMMA INTERFERON; GLUCOSE; HEME OXYGENASE 1; HERBACEOUS AGENT; INSULIN; INTERLEUKIN 4; MOMORDICA GROSVENORI EXTRACT; PLANT EXTRACT; SWEETENING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHINESE HERB; CONTROLLED STUDY; DIABETES CONTROL; DOSE RESPONSE; DRUG MECHANISM; ENZYME INDUCTION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOMODULATION; INSULIN BLOOD LEVEL; MALE; MOMORDICA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; UPREGULATION;

ALLOXAN; ANIMALS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; IMMUNITY; MALE; MICE; MICE, INBRED BALB C; MOMORDICA; PHYTOTHERAPY; PLANT EXTRACTS; SPLEEN; SWEETENING AGENTS; TH1 CELLS; TH2 CELLS;

MOMORDICA;

EID: 33746021379     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1903     Document Type: Article

References (30)

1. Abdel-Aziz MT, El-Asmar MF, El-Miligy D et al. 2003. Retrovirus-mediated human heme oxygenase-1 (HO-1) gene transfer into rat endothelial cells: the effect of HO-1 inducers on the expression of cytokines. Int J Biochem Cell Biol 35: 324-332.
2. Al-Kassab AS, Raziuddin S. 1990. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus. Clin Exp Immunol 81: 267-271.
3. Cetkovic-Cvrlje M, Dragt AL, Vassilev A, Liu XP, Uckun FM. 2003. Targeting JAK3 with JANEX-1 for prevention of autoimmune type 1 diabetes in NOD mice. Clin Immunol 106: 213-225.
4. Falcone M, Yeung B, Tucker L, Rodriguez E, Krahl T, Sarvetnick N. 2001. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic islets. Clin Immunol 98: 190-199.
5. Farhangkhoee H, Khan ZA, Mukherjee S et al. 2003. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 35: 1439-1448.
6. Flohe SB, Wasmuth HE, Kerad JB et al. 2003. A wheat-based, diabetes-promoting diet induces a Th1-type cytokine bias in the gut of NOD mice. Cytokine 21: 149-154.
7. Gray RS, Cowan P, Duncan LJ, Clarke BF. 1986. Reversal of insulin resistance in type 1 diabetes following initiation of insulin treatment. Diabet Med 3: 18-23.
8. Greenbaum CJ. 2002. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 18: 192-200.
9. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. 2003. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 26: 138-143.
10. Hayashi K, Haneda M, Koya D, Maeda S, Isshiki K, Kikkawa R. 2001. Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Prac 52: 85-96.
11. Horikia M, Yamato E, Noso S, Ikegami H, Ogihara T, Miyazaki J. 2003. High-level expression of interleukin-4 following electroporation-mediated gene transfer accelerates Type 1 diabetes in NOD mice. J Autoimmun 20: 111-117.
12. Lavrovsky Y, Drummond GS, Abraham NG. 1996. Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements. Biochem Biophys Res Commun 218: 759-765.
13. McCulloch DK, Kahn SE, Schwartz MW, Koerker DJ, Palmer JP. 1991. Effect of nicotinic acid-induced insulin resistance on pancreatic B cell function in normal and streptozocin-treated baboons. J Clin Invest 87: 1395-1401.
14. Peakman M, Warnock T, Vats A et al. 1994. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA-DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives. Diabetologia 37: 155-165.
15. Petersen LD, Duinkerken G, Bruining GJ, van Lier RA, de Vries RR, Roep BO. 1996. Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus. J Autoimmun 9: 731-737.
16. Pileggi A, Molano RD, Berney T et al. 2001. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50: 1983-1991.
17. Pontesilli O, Chase HP, Carotenuto P, Herberger MJ, Hayward AR. 1986. T-lymphocyte subpopulations in insulin-dependent (type I) diabetes mellitus. Clin Exp Immunol 63: 68-72.
18. Quan S, Kaminski PM, Yang L et al. 2004. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315: 509-516.
19. Ribeiro MM, Klein D, Pileggi A et al. 2003. Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. Biochem Biophys Res Commun 305: 876-881.
20. Simoni J, Simoni G, Lox CD, McGunegle DE, Feola M. 1994. Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol 22: 525-534.
21. Takasaki M, Konoshima T, Murata Y et al. 2003. Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori. Cancer Lett 198: 37-42.
22. Takemoto T, Arihara S, Nakajima T, Okuhira M. 1983. Studies on the constituents of Fructus Momordicae I, II, III. Yakugaku Zasshi 103: 1151-1173.
23. Takeo E, Yoshida H, Tada N et al. 2002. Sweet elements of Siraitia (Momordica grosvenori) inhibit oxidative modification of low density lipoprotein. J Atheroscler Thromb 9: 114-120.
24. Thorvaldson L, Holstad M, Sandler S. 2003. Cytokine release by murine spleen cells following multiple low dose streptozotocin-induced diabetes and treatment with a TNF- a transcriptional inhibitor. Int Immunopharmacol 3: 1609-1617.
25. Tobiasch E, Gunther L, Bach FH. 2001. Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J Investig Med 49: 566-571.
26. Trekli MC, Riss G, Goralczyk R, Tyrrell RM. 2003. Beta-carotene suppresses UVA-induced HO-1 gene expression in cultured FEK4. Free Radic Biol Med 34: 456-464.
27. Tsang KY, Ng TB. 2001. Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Momordica grosvenorii. Life Sci 68: 773-784.
28. Ukiya M, Akihisa T, Tokuda H et al. 2002. Inhibitory effects of cucurbitane glycosides and other triterpenoids from the fruit of Momordica grosvenori on Epstein-Barr virus early antigen induced by tumor promoter 12-O-tetradecanoylphorbol-13-acetate. J Agric Food Chem 50: 6710-6715.
29. Weiss L, Barak V, Zeira M et al. 2002. Cytokine production in linomide-treated NOD mice and the potential role of a Th 1/ Th2 shift on autoimmune and anti-inflammatory processes. Cytokine 19: 85-93.
30. Yki-Jarvinen H, Koivisto VA. 1986. Natural course of insulin resistance in type I diabetes. N Engl J Med 315: 224-230.